Pain Management Treatment Market to Catapult by 2018

(firmenpresse) - NEW YORK, NY -- (Marketwire) -- 03/11/13 -- TriMarkPublications.com cites in its newly published " Treatment Markets" report that the treatment market will catapult by 2018. For more information, visit: .
drugs, or analgesics, can be categorized into three main modalities: acetaminophen, NSAIDs and opioids. Pain, meanwhile, can be categorized into four main modalities: acute, chronic, neuropathic and nociceptive. The market is currently valued at $52 billion. Growing at a rate of 20%, the opioid segment will constitute a full 43% of the market by 2018. Although the U.S. market will only increase modestly to $21.8 billion, it remains the largest market by far throughout the forecast period.
The " Treatment Markets" report covers:
CGRP antagonists
CB2 agonists
Sodium channel modulators
Calcium channel modulators
NMDA antagonists
P2x receptors
Trp channels
TrpV1 blockers
FAAH inhibitors
Novel opioids
Extended release formulations
Transdermal formulations
The " Treatment Markets" report examines companies manufacturing equipment and supplies in the world. Companies covered include: Abbott, AcelRx, Acura, Afferent, Algiax, Arcion, Astellas, BioDelivery Sciences, Cara, Cephalon, Convergence, Cytogel, DURECT, Egalet, Eli Lilly, Endo, Grünenthal, Hospira, iMed, Johnson & Johnson, KemPharm, Mallinckrodt, NeurAxon, NeurogesX, Newron, Novartis, Nuvo, Pacira, Pain Therapeutics, Pfizer, Purdue, QRx, Relevare, Relmada, Spinifex, Xenon, Xenoport, Zalicus and Zogenix.
Detailed charts with sales forecasts and marketshare data are included. For more information, visit: .
TriMarkPublications.com is a global leader in the biotechnology, healthcare and life sciences market research publishing. For more information, please visit .
The statements contained in this news release that are forward-looking are based on current expectations that are subject to a number of uncertainties and risks, and actual results may differ materially.
TriMarkPublications.com
Media Relations
1-888-OK-TRIMARK
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Bereitgestellt von Benutzer: MARKETWIRE
Datum: 11.03.2013 - 17:00 Uhr
Sprache: Deutsch
News-ID 238109
Anzahl Zeichen: 0
contact information:
Town:
NEW YORK, NY
Kategorie:
Health & Nutrition
Diese Pressemitteilung wurde bisher 257 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Pain Management Treatment Market to Catapult by 2018"
steht unter der journalistisch-redaktionellen Verantwortung von
TriMarkPublications.com (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).